GIP & GLP-1 is an innovative peptide designed to aid in weight management and improve glycemic control
Although skeletal effects are beneficial in preclinical investigations, clinical evidence on fracture risk is still uncertain
Traditional approaches to obesity management, including lifestyle interventions and older pharmacotherapies, have historically demonstrated limited long-term efficacy, creating an urgent need for more effective therapeutic options
Keep making progress with regular check-ins, expert guidance, and access to your care team 24/7
Why Medical Guidance Matters Retatrutide dosing should always be personalized
Foundayo is FDA-approved for adults with a BMI of 30 or greater (obesity), or a BMI of 27 or greater with at least one weight-related health condition such as high blood pressure, high cholesterol, or type 2 diabetes